Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models.

Stephen B Duffull, Andrew C Hooker
Author Information
  1. Stephen B Duffull: School of Pharmacy, University of Otago, 18 Frederick St, Dunedin, New Zealand. stephen.duffull@otago.ac.nz.
  2. Andrew C Hooker: Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

Abstract

Optimal designs for nonlinear models are dependent on the choice of parameter values. Various methods have been proposed to provide designs that are robust to uncertainty in the prior choice of parameter values. These methods are generally based on estimating the expectation of the determinant (or a transformation of the determinant) of the information matrix over the prior distribution of the parameter values. For high dimensional models this can be computationally challenging. For nonlinear mixed-effects models the question arises as to the importance of accounting for uncertainty in the prior value of the variances of the random effects parameters. In this work we explore the influence of the variance of the random effects parameters on the optimal design. We find that the method for approximating the expectation and variance of the likelihood is of potential importance for considering the influence of random effects. The most common approximation to the likelihood, based on a first-order Taylor series approximation, yields designs that are relatively insensitive to the prior value of the variance of the random effects parameters and under these conditions it appears to be sufficient to consider uncertainty on the fixed-effects parameters only.

Keywords

References

  1. CPT Pharmacometrics Syst Pharmacol. 2013 Jun 05;2:e46 [PMID: 23887744]
  2. Comput Methods Programs Biomed. 2004 Apr;74(1):29-46 [PMID: 14992824]
  3. J Biopharm Stat. 2010 Jul;20(4):886-902 [PMID: 20496212]
  4. Pharm Res. 2012 Jun;29(6):1530-43 [PMID: 22350799]
  5. Br J Clin Pharmacol. 2015 Jan;79(1):6-17 [PMID: 24548174]
  6. J Biopharm Stat. 2003 May;13(2):209-27 [PMID: 12729390]
  7. J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):33-64 [PMID: 16205840]
  8. J Biopharm Stat. 2014;24(3):471-92 [PMID: 24697342]
  9. Math Biosci. 1990 Apr;99(1):105-18 [PMID: 2134510]
  10. J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):609-619 [PMID: 27804003]
  11. J Clin Invest. 1963 Oct;42:1542-51 [PMID: 14074349]
  12. Circulation. 1968 Jul;38(1):169-77 [PMID: 11712286]
  13. J Biopharm Stat. 2012;22(6):1193-205 [PMID: 23075017]

MeSH Term

Computer Simulation
Humans
Models, Biological
Models, Statistical
Nonlinear Dynamics
Uncertainty